img

Global Specialty Pharmaceutical Market Report, History and Forecast 2018-2034, Breakdown Data by Manufacturers, Key Regions, Types and Application


Published on: 2024-01-04 | No of Pages : 400 | Industry : Pharma & Healthcare

Publisher : MRA | Format : PDF

Global Specialty Pharmaceutical Market Report, History and Forecast 2018-2034, Breakdown Data by Manufacturers, Key Regions, Types and Application

Specialty pharmaceuticals are a recent designation of pharmaceuticals that are classified as high-cost, high complexity and/or high touch.
Specialty Pharmaceutical report published by QYResearch reveals that COVID-19 and Russia-Ukraine War impacted the market dually in 2022. Global Specialty Pharmaceutical market is projected to reach US$ million in 2034, increasing from US$ million in 2022, with the CAGR of % during the period of 2024 to 2034. Demand from Tumor and Diabetes are the major drivers for the industry.
North America, Europe and Asia Pacific are the key regions for Specialty Pharmaceutical industry. Among those areas, stimulated by rigid demand from downstream industries, Asia Pacific is estimated to experience fast growth, with the CAGR of % during 2024 to 2034.
Globally, Specialty Pharmaceutical key manufacturers include Pfizer, Roche, Amgen, AbbVie, Novo Nordisk, Johnson & Johnson, Sanofi-Aventis, Merck and Eli Lilly, etc. Pfizer, Roche, Amgen are top 3 players and held % sales share in total in 2022.
Specialty Pharmaceutical can be divided into Antibody, Hormone, Growth Factors and Other, etc. Antibody is the mainstream product in the market, accounting for % sales share globally in 2022.
Specialty Pharmaceutical is widely used in various fields, such as Tumor, Diabetes, Cardiovascular and Hemophilia, etc. Tumor provides greatest supports to the Specialty Pharmaceutical industry development. In 2022, global % sales of Specialty Pharmaceutical went into Tumor filed.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2024-2034), aims to help readers to get a comprehensive understanding of global Specialty Pharmaceutical market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
Manufacturers, Type, Application and Regions Listed in the Report



By Company


Pfizer
Roche
Amgen
AbbVie
Novo Nordisk
Johnson & Johnson
Sanofi-Aventis
Merck
Eli Lilly
Novartis
3sbio
Changchun High Tech
CP Guojian Pharmacy
Biotech Pharma
Gelgen Biopharma
Innovent
Segment by Type
Antibody
Hormone
Growth Factors
Other

Segment by Application


Tumor
Diabetes
Cardiovascular
Hemophilia
Other

Segment by Region


North America
the United States
Canada
Europe
Germany
France
UK
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Each chapter of the report provides detailed information for readers to understand the Specialty Pharmaceutical market further
Chapter 1Product Definition, Product Types, Volume and Revenue analysis of Each Type in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2024.
Chapter 2Manufacturer Competition Status, including Sales and Revenue comparison, Manufacturers’ commercial date of Specialty Pharmaceutical, product type offered by each manufacturer, Mergers & Acquisitions activities, Expansion activities occurred in the Specialty Pharmaceutical industry.
Chapter 3Historical (2018-2022) and forecast (2024-2034) volume and revenue analysis of Specialty Pharmaceutical in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa.
Chapter 4Product Application, Volume and Revenue analysis of Each Application in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2024.
Chapter 5 to 9Country Level analysis of North America, Europe, Asia-Pacific, Latin America, Middle East and Africa, including volume and revenue analysis.
Chapter 10Manufacturers’ Outline, covering company’s basic information like headquarter, contact information, major business, Specialty Pharmaceutical introduction, etc. Specialty Pharmaceutical Sales, Revenue, Price and Gross Margin of each company as well as Recent Development are also contained in this part.
Chapter 11Industry Chain, like raw materials, manufacturing cost, are covered. In addition, market opportunities and challenges are emphasized as well in the chapter.
Chapter 12Market Channel, Distributors and Customers are listed.
Chapter 13QYResearch’s Conclusions of Specialty Pharmaceutical market based on comprehensive survey.
Chapter 14Methodology and Data Sources adopted by QYResearch.

Table of Content

1 Specialty Pharmaceutical Market Overview
1.1 Specialty Pharmaceutical Product Overview
1.2 Specialty Pharmaceutical Market Segment by Type
1.2.1 Antibody
1.2.2 Hormone
1.2.3 Growth Factors
1.2.4 Other
1.3 Global Specialty Pharmaceutical Market Size by Type
1.3.1 Global Specialty Pharmaceutical Market Size Overview by Type (2018-2034)
1.3.2 Global Specialty Pharmaceutical Historic Market Size Review by Type (2018-2024)
1.3.3 Global Specialty Pharmaceutical Forecasted Market Size by Type (2024-2034)
1.4 Key Regions Market Size Segment by Type
1.4.1 North America Specialty Pharmaceutical Sales Breakdown by Type (2018-2024)
1.4.2 Europe Specialty Pharmaceutical Sales Breakdown by Type (2018-2024)
1.4.3 Asia-Pacific Specialty Pharmaceutical Sales Breakdown by Type (2018-2024)
1.4.4 Latin America Specialty Pharmaceutical Sales Breakdown by Type (2018-2024)
1.4.5 Middle East and Africa Specialty Pharmaceutical Sales Breakdown by Type (2018-2024)
2 Global Specialty Pharmaceutical Market Competition by Company
2.1 Global Top Players by Specialty Pharmaceutical Sales (2018-2024)
2.2 Global Top Players by Specialty Pharmaceutical Revenue (2018-2024)
2.3 Global Top Players by Specialty Pharmaceutical Price (2018-2024)
2.4 Global Top Manufacturers Specialty Pharmaceutical Manufacturing Base Distribution, Sales Area, Product Type
2.5 Specialty Pharmaceutical Market Competitive Situation and Trends
2.5.1 Specialty Pharmaceutical Market Concentration Rate (2018-2024)
2.5.2 Global 5 and 10 Largest Manufacturers by Specialty Pharmaceutical Sales and Revenue in 2022
2.6 Global Top Manufacturers by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Specialty Pharmaceutical as of 2022)
2.7 Date of Key Manufacturers Enter into Specialty Pharmaceutical Market
2.8 Key Manufacturers Specialty Pharmaceutical Product Offered
2.9 Mergers & Acquisitions, Expansion
3 Specialty Pharmaceutical Status and Outlook by Region
3.1 Global Specialty Pharmaceutical Market Size and CAGR by Region: 2018 VS 2022 VS 2034
3.2 Global Specialty Pharmaceutical Historic Market Size by Region
3.2.1 Global Specialty Pharmaceutical Sales in Volume by Region (2018-2024)
3.2.2 Global Specialty Pharmaceutical Sales in Value by Region (2018-2024)
3.2.3 Global Specialty Pharmaceutical Sales (Volume & Value) Price and Gross Margin (2018-2024)
3.3 Global Specialty Pharmaceutical Forecasted Market Size by Region
3.3.1 Global Specialty Pharmaceutical Sales in Volume by Region (2024-2034)
3.3.2 Global Specialty Pharmaceutical Sales in Value by Region (2024-2034)
3.3.3 Global Specialty Pharmaceutical Sales (Volume & Value), Price and Gross Margin (2024-2034)
4 Global Specialty Pharmaceutical by Application
4.1 Specialty Pharmaceutical Market Segment by Application
4.1.1 Tumor
4.1.2 Diabetes
4.1.3 Cardiovascular
4.1.4 Hemophilia
4.1.5 Other
4.2 Global Specialty Pharmaceutical Market Size by Application
4.2.1 Global Specialty Pharmaceutical Market Size Overview by Application (2018-2034)
4.2.2 Global Specialty Pharmaceutical Historic Market Size Review by Application (2018-2024)
4.2.3 Global Specialty Pharmaceutical Forecasted Market Size by Application (2024-2034)
4.3 Key Regions Market Size Segment by Application
4.3.1 North America Specialty Pharmaceutical Sales Breakdown by Application (2018-2024)
4.3.2 Europe Specialty Pharmaceutical Sales Breakdown by Application (2018-2024)
4.3.3 Asia-Pacific Specialty Pharmaceutical Sales Breakdown by Application (2018-2024)
4.3.4 Latin America Specialty Pharmaceutical Sales Breakdown by Application (2018-2024)
4.3.5 Middle East and Africa Specialty Pharmaceutical Sales Breakdown by Application (2018-2024)
5 North America Specialty Pharmaceutical by Country
5.1 North America Specialty Pharmaceutical Historic Market Size by Country
5.1.1 North America Specialty Pharmaceutical Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2034
5.1.2 North America Specialty Pharmaceutical Sales in Volume by Country (2018-2024)
5.1.3 North America Specialty Pharmaceutical Sales in Value by Country (2018-2024)
5.2 North America Specialty Pharmaceutical Forecasted Market Size by Country
5.2.1 North America Specialty Pharmaceutical Sales in Volume by Country (2024-2034)
5.2.2 North America Specialty Pharmaceutical Sales in Value by Country (2024-2034)
6 Europe Specialty Pharmaceutical by Country
6.1 Europe Specialty Pharmaceutical Historic Market Size by Country
6.1.1 Europe Specialty Pharmaceutical Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2034
6.1.2 Europe Specialty Pharmaceutical Sales in Volume by Country (2018-2024)
6.1.3 Europe Specialty Pharmaceutical Sales in Value by Country (2018-2024)
6.2 Europe Specialty Pharmaceutical Forecasted Market Size by Country
6.2.1 Europe Specialty Pharmaceutical Sales in Volume by Country (2024-2034)
6.2.2 Europe Specialty Pharmaceutical Sales in Value by Country (2024-2034)
7 Asia-Pacific Specialty Pharmaceutical by Region
7.1 Asia-Pacific Specialty Pharmaceutical Historic Market Size by Region
7.1.1 Asia-Pacific Specialty Pharmaceutical Market Size Growth Rate (CAGR) by Region: 2018 VS 2022 VS 2034
7.1.2 Asia-Pacific Specialty Pharmaceutical Sales in Volume by Region (2018-2024)
7.1.3 Asia-Pacific Specialty Pharmaceutical Sales in Value by Region (2018-2024)
7.2 Asia-Pacific Specialty Pharmaceutical Forecasted Market Size by Region
7.2.1 Asia-Pacific Specialty Pharmaceutical Sales in Volume by Region (2024-2034)
7.2.2 Asia-Pacific Specialty Pharmaceutical Sales in Value by Region (2024-2034)
8 Latin America Specialty Pharmaceutical by Country
8.1 Latin America Specialty Pharmaceutical Historic Market Size by Country
8.1.1 Latin America Specialty Pharmaceutical Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2034
8.1.2 Latin America Specialty Pharmaceutical Sales in Volume by Country (2018-2024)
8.1.3 Latin America Specialty Pharmaceutical Sales in Value by Country (2018-2024)
8.2 Latin America Specialty Pharmaceutical Forecasted Market Size by Country
8.2.1 Latin America Specialty Pharmaceutical Sales in Volume by Country (2024-2034)
8.2.2 Latin America Specialty Pharmaceutical Sales in Value by Country (2024-2034)
9 Middle East and Africa Specialty Pharmaceutical by Country
9.1 Middle East and Africa Specialty Pharmaceutical Historic Market Size by Country
9.1.1 Middle East and Africa Specialty Pharmaceutical Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2034
9.1.2 Middle East and Africa Specialty Pharmaceutical Sales in Volume by Country (2018-2024)
9.1.3 Middle East and Africa Specialty Pharmaceutical Sales in Value by Country (2018-2024)
9.2 Middle East and Africa Specialty Pharmaceutical Forecasted Market Size by Country
9.2.1 Middle East and Africa Specialty Pharmaceutical Sales in Volume by Country (2024-2034)
9.2.2 Middle East and Africa Specialty Pharmaceutical Sales in Value by Country (2024-2034)
10 Company Profiles
10.1 Pfizer
10.1.1 Pfizer Company Information
10.1.2 Pfizer Introduction and Business Overview
10.1.3 Pfizer Specialty Pharmaceutical Sales, Revenue and Gross Margin (2018-2024)
10.1.4 Pfizer Specialty Pharmaceutical Products Offered
10.1.5 Pfizer Recent Development
10.2 Roche
10.2.1 Roche Company Information
10.2.2 Roche Introduction and Business Overview
10.2.3 Roche Specialty Pharmaceutical Sales, Revenue and Gross Margin (2018-2024)
10.2.4 Roche Specialty Pharmaceutical Products Offered
10.2.5 Roche Recent Development
10.3 Amgen
10.3.1 Amgen Company Information
10.3.2 Amgen Introduction and Business Overview
10.3.3 Amgen Specialty Pharmaceutical Sales, Revenue and Gross Margin (2018-2024)
10.3.4 Amgen Specialty Pharmaceutical Products Offered
10.3.5 Amgen Recent Development
10.4 AbbVie
10.4.1 AbbVie Company Information
10.4.2 AbbVie Introduction and Business Overview
10.4.3 AbbVie Specialty Pharmaceutical Sales, Revenue and Gross Margin (2018-2024)
10.4.4 AbbVie Specialty Pharmaceutical Products Offered
10.4.5 AbbVie Recent Development
10.5 Novo Nordisk
10.5.1 Novo Nordisk Company Information
10.5.2 Novo Nordisk Introduction and Business Overview
10.5.3 Novo Nordisk Specialty Pharmaceutical Sales, Revenue and Gross Margin (2018-2024)
10.5.4 Novo Nordisk Specialty Pharmaceutical Products Offered
10.5.5 Novo Nordisk Recent Development
10.6 Johnson & Johnson
10.6.1 Johnson & Johnson Company Information
10.6.2 Johnson & Johnson Introduction and Business Overview
10.6.3 Johnson & Johnson Specialty Pharmaceutical Sales, Revenue and Gross Margin (2018-2024)
10.6.4 Johnson & Johnson Specialty Pharmaceutical Products Offered
10.6.5 Johnson & Johnson Recent Development
10.7 Sanofi-Aventis
10.7.1 Sanofi-Aventis Company Information
10.7.2 Sanofi-Aventis Introduction and Business Overview
10.7.3 Sanofi-Aventis Specialty Pharmaceutical Sales, Revenue and Gross Margin (2018-2024)
10.7.4 Sanofi-Aventis Specialty Pharmaceutical Products Offered
10.7.5 Sanofi-Aventis Recent Development
10.8 Merck
10.8.1 Merck Company Information
10.8.2 Merck Introduction and Business Overview
10.8.3 Merck Specialty Pharmaceutical Sales, Revenue and Gross Margin (2018-2024)
10.8.4 Merck Specialty Pharmaceutical Products Offered
10.8.5 Merck Recent Development
10.9 Eli Lilly
10.9.1 Eli Lilly Company Information
10.9.2 Eli Lilly Introduction and Business Overview
10.9.3 Eli Lilly Specialty Pharmaceutical Sales, Revenue and Gross Margin (2018-2024)
10.9.4 Eli Lilly Specialty Pharmaceutical Products Offered
10.9.5 Eli Lilly Recent Development
10.10 Novartis
10.10.1 Novartis Company Information
10.10.2 Novartis Introduction and Business Overview
10.10.3 Novartis Specialty Pharmaceutical Sales, Revenue and Gross Margin (2018-2024)
10.10.4 Novartis Specialty Pharmaceutical Products Offered
10.10.5 Novartis Recent Development
10.11 3sbio
10.11.1 3sbio Company Information
10.11.2 3sbio Introduction and Business Overview
10.11.3 3sbio Specialty Pharmaceutical Sales, Revenue and Gross Margin (2018-2024)
10.11.4 3sbio Specialty Pharmaceutical Products Offered
10.11.5 3sbio Recent Development
10.12 Changchun High Tech
10.12.1 Changchun High Tech Company Information
10.12.2 Changchun High Tech Introduction and Business Overview
10.12.3 Changchun High Tech Specialty Pharmaceutical Sales, Revenue and Gross Margin (2018-2024)
10.12.4 Changchun High Tech Specialty Pharmaceutical Products Offered
10.12.5 Changchun High Tech Recent Development
10.13 CP Guojian Pharmacy
10.13.1 CP Guojian Pharmacy Company Information
10.13.2 CP Guojian Pharmacy Introduction and Business Overview
10.13.3 CP Guojian Pharmacy Specialty Pharmaceutical Sales, Revenue and Gross Margin (2018-2024)
10.13.4 CP Guojian Pharmacy Specialty Pharmaceutical Products Offered
10.13.5 CP Guojian Pharmacy Recent Development
10.14 Biotech Pharma
10.14.1 Biotech Pharma Company Information
10.14.2 Biotech Pharma Introduction and Business Overview
10.14.3 Biotech Pharma Specialty Pharmaceutical Sales, Revenue and Gross Margin (2018-2024)
10.14.4 Biotech Pharma Specialty Pharmaceutical Products Offered
10.14.5 Biotech Pharma Recent Development
10.15 Gelgen Biopharma
10.15.1 Gelgen Biopharma Company Information
10.15.2 Gelgen Biopharma Introduction and Business Overview
10.15.3 Gelgen Biopharma Specialty Pharmaceutical Sales, Revenue and Gross Margin (2018-2024)
10.15.4 Gelgen Biopharma Specialty Pharmaceutical Products Offered
10.15.5 Gelgen Biopharma Recent Development
10.16 Innovent
10.16.1 Innovent Company Information
10.16.2 Innovent Introduction and Business Overview
10.16.3 Innovent Specialty Pharmaceutical Sales, Revenue and Gross Margin (2018-2024)
10.16.4 Innovent Specialty Pharmaceutical Products Offered
10.16.5 Innovent Recent Development
11 Upstream, Opportunities, Challenges, Risks and Influences Factors Analysis
11.1 Specialty Pharmaceutical Key Raw Materials
11.1.1 Key Raw Materials
11.1.2 Key Raw Materials Price
11.1.3 Raw Materials Key Suppliers
11.2 Manufacturing Cost Structure
11.2.1 Raw Materials
11.2.2 Labor Cost
11.2.3 Manufacturing Expenses
11.3 Specialty Pharmaceutical Industrial Chain Analysis
11.4 Specialty Pharmaceutical Market Dynamics
11.4.1 Specialty Pharmaceutical Industry Trends
11.4.2 Specialty Pharmaceutical Market Drivers
11.4.3 Specialty Pharmaceutical Market Challenges
11.4.4 Specialty Pharmaceutical Market Restraints
12 Market Strategy Analysis, Distributors
12.1 Sales Channel
12.2 Specialty Pharmaceutical Distributors
12.3 Specialty Pharmaceutical Downstream Customers
13 Research Findings and Conclusion
14 Appendix
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.2 Data Source
14.2 Author Details
14.3 Disclaimer

List of Figure

List of Tables
Table 1. Major Company of Antibody
Table 2. Major Company of Hormone
Table 3. Major Company of Growth Factors
Table 4. Major Company of Other
Table 5. Global Specialty Pharmaceutical Sales by Type 2018 VS 2022 VS 2034 (US$ Million)
Table 6. Global Specialty Pharmaceutical Sales by Type (2018-2024) & (MT)
Table 7. Global Specialty Pharmaceutical Sales Market Share in Volume by Type (2018-2024)
Table 8. Global Specialty Pharmaceutical Sales by Type (2018-2024) & (US& Million)
Table 9. Global Specialty Pharmaceutical Market Share in Value by Type (2018-2024)
Table 10. Global Specialty Pharmaceutical Price by Type (2018-2024) & (USD/Kg)
Table 11. Global Specialty Pharmaceutical Sales by Type (2024-2034) & (MT)
Table 12. Global Specialty Pharmaceutical Sales Market Share in Volume by Type (2024-2034)
Table 13. Global Specialty Pharmaceutical Sales by Type (2024-2034) & (US$ Million)
Table 14. Global Specialty Pharmaceutical Sales Market Share in Value by Type (2024-2034)
Table 15. Global Specialty Pharmaceutical Price by Type (2024-2034) & (USD/Kg)
Table 16. North America Specialty Pharmaceutical Sales by Type (2018-2024) & (MT)
Table 17. North America Specialty Pharmaceutical Sales by Type (2018-2024) & (US$ Million)
Table 18. Europe Specialty Pharmaceutical Sales (MT) by Type (2018-2024)
Table 19. Europe Specialty Pharmaceutical Sales by Type (2018-2024) & (US$ Million)
Table 20. Asia-Pacific Specialty Pharmaceutical Sales (MT) by Type (2018-2024)
Table 21. Asia-Pacific Specialty Pharmaceutical Sales by Type (2018-2024) & (US$ Million)
Table 22. Latin America Specialty Pharmaceutical Sales (MT) by Type (2018-2024)
Table 23. Latin America Specialty Pharmaceutical Sales by Type (2018-2024) & (US$ Million)
Table 24. Middle East and Africa Specialty Pharmaceutical Sales (MT) by Type (2018-2024)
Table 25. Middle East and Africa Specialty Pharmaceutical Sales by Type (2018-2024) & (US$ Million)
Table 26. Global Specialty Pharmaceutical Sales by Company (2018-2024) & (MT)
Table 27. Global Specialty Pharmaceutical Sales Share by Company (2018-2024)
Table 28. Global Specialty Pharmaceutical Revenue by Company (2018-2024) & (US$ Million)
Table 29. Global Specialty Pharmaceutical Revenue Share by Company (2018-2024)
Table 30. Global Market Specialty Pharmaceutical Price by Company (2018-2024) & (USD/Kg)
Table 31. Global Specialty Pharmaceutical Top Manufacturers Manufacturing Base Distribution and Sales Area
Table 32. Global Specialty Pharmaceutical Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 33. Global Top Manufacturers Market Share by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Specialty Pharmaceutical as of 2022)
Table 34. Date of Key Manufacturers Enter into Specialty Pharmaceutical Market
Table 35. Key Manufacturers Specialty Pharmaceutical Product Type
Table 36. Mergers & Acquisitions, Expansion Plans
Table 37. Global Specialty Pharmaceutical Market Size Comparison by Region (US$ Million): 2018 VS 2022 VS 2034
Table 38. Global Specialty Pharmaceutical Sales by Region (2018-2024) & (MT)
Table 39. Global Specialty Pharmaceutical Sales Market Share in Volume by Region (2018-2024)
Table 40. Global Specialty Pharmaceutical Sales by Region (2018-2024) & (US$ Million)
Table 41. Global Specialty Pharmaceutical Sales Market Share in Value by Region (2018-2024)
Table 42. Global Specialty Pharmaceutical Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2018-2024)
Table 43. Global Specialty Pharmaceutical Sales by Region (2024-2034) & (MT)
Table 44. Global Specialty Pharmaceutical Sales Market Share in Volume by Region (2024-2034)
Table 45. Global Specialty Pharmaceutical Sales by Region (2024-2034) & (US$ Million)
Table 46. Global Specialty Pharmaceutical Sales Market Share in Value by Region (2024-2034)
Table 47. Global Specialty Pharmaceutical Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2024-2034)
Table 48. Global Specialty Pharmaceutical Sales by Application: 2018 VS 2022 VS 2034 (US$ Million)
Table 49. Global Specialty Pharmaceutical Sales by Application (2018-2024) & (MT)
Table 50. Global Specialty Pharmaceutical Sales Market Share in Volume by Application (2018-2024)
Table 51. Global Specialty Pharmaceutical Sales by Application (2018-2024) & (US$ Million)
Table 52. Global Specialty Pharmaceutical Sales Market Share in Value by Application (2018-2024)
Table 53. Global Specialty Pharmaceutical Price by Application (2018-2024) & (USD/Kg)
Table 54. Global Specialty Pharmaceutical Sales by Application (2024-2034) & (MT)
Table 55. Global Specialty Pharmaceutical Sales Market Share in Volume by Application (2024-2034)
Table 56. Global Specialty Pharmaceutical Sales by Application (2024-2034) & (US$ Million)
Table 57. Global Specialty Pharmaceutical Sales Market Share in Value by Application (2024-2034)
Table 58. Global Specialty Pharmaceutical Price by Application (2024-2034) & (USD/Kg)
Table 59. North America Specialty Pharmaceutical Sales by Application (2018-2024) (MT)
Table 60. North America Specialty Pharmaceutical Sales by Application (2018-2024) & (US$ Million)
Table 61. Europe Specialty Pharmaceutical Sales by Application (2018-2024) (MT)
Table 62. Europe Specialty Pharmaceutical Sales by Application (2018-2024) & (US$ Million)
Table 63. Asia-Pacific Specialty Pharmaceutical Sales by Application (2018-2024) (MT)
Table 64. Asia-Pacific Specialty Pharmaceutical Sales by Application (2018-2024) & (US$ Million)
Table 65. Latin America Specialty Pharmaceutical Sales by Application (2018-2024) (MT)
Table 66. Latin America Specialty Pharmaceutical Sales by Application (2018-2024) & (US$ Million)
Table 67. Middle East and Africa Specialty Pharmaceutical Sales by Application (2018-2024) (MT)
Table 68. Middle East and Africa Specialty Pharmaceutical Sales by Application (2018-2024) & (US$ Million)
Table 69. North America Specialty Pharmaceutical Sales by Country (2018-2024) & (MT)
Table 70. North America Specialty Pharmaceutical Sales Market Share in Volume by Country (2018-2024)
Table 71. North America Specialty Pharmaceutical Sales by Country (2018-2024) & (US$ Million)
Table 72. North America Specialty Pharmaceutical Sales Market Share in Value by Country (2018-2024)
Table 73. North America Specialty Pharmaceutical Sales by Country (2024-2034) & (MT)
Table 74. North America Specialty Pharmaceutical Sales Market Share in Volume by Country (2024-2034)
Table 75. North America Specialty Pharmaceutical Sales by Country (2024-2034) & (US$ Million)
Table 76. North America Specialty Pharmaceutical Sales Market Share in Value by Country (2024-2034)
Table 77. Europe Specialty Pharmaceutical Sales by Country (2018-2024) & (MT)
Table 78. Europe Specialty Pharmaceutical Sales Market Share in Volume by Country (2018-2024)
Table 79. Europe Specialty Pharmaceutical Sales by Country (2018-2024) & (US$ Million)
Table 80. Europe Specialty Pharmaceutical Sales Market Share in Value by Country (2018-2024)
Table 81. Europe Specialty Pharmaceutical Sales by Country (2024-2034) & (MT)
Table 82. Europe Specialty Pharmaceutical Sales Market Share in Volume by Country (2024-2034)
Table 83. Europe Specialty Pharmaceutical Sales by Country (2024-2034) & (US$ Million)
Table 84. Europe Specialty Pharmaceutical Sales Market Share in Value by Country (2024-2034)
Table 85. Asia-Pacific Specialty Pharmaceutical Sales by Region (2018-2024) & (MT)
Table 86. Asia-Pacific Specialty Pharmaceutical Sales Market Share in Volume by Region (2018-2024)
Table 87. Asia-Pacific Specialty Pharmaceutical Sales by Region (2018-2024) & (US$ Million)
Table 88. Asia-Pacific Specialty Pharmaceutical Sales Market Share in Value by Region (2018-2024)
Table 89. Asia-Pacific Specialty Pharmaceutical Sales by Region (2024-2034) & (MT)
Table 90. Asia-Pacific Specialty Pharmaceutical Sales Market Share in Volume by Region (2024-2034)
Table 91. Asia-Pacific Specialty Pharmaceutical Sales by Region (2024-2034) & (US$ Million)
Table 92. Asia-Pacific Specialty Pharmaceutical Sales Market Share in Value by Region (2024-2034)
Table 93. Latin America Specialty Pharmaceutical Sales by Country (2018-2024) & (MT)
Table 94. Latin America Specialty Pharmaceutical Sales Market Share in Volume by Country (2018-2024)
Table 95. Latin America Specialty Pharmaceutical Sales by Country (2018-2024) & (US$ Million)
Table 96. Latin America Specialty Pharmaceutical Sales Market Share in Value by Country (2018-2024)
Table 97. Latin America Specialty Pharmaceutical Sales by Country (2024-2034) & (MT)
Table 98. Latin America Specialty Pharmaceutical Sales Market Share in Volume by Country (2024-2034)
Table 99. Latin America Specialty Pharmaceutical Sales by Country (2024-2034) & (US$ Million)
Table 100. Latin America Specialty Pharmaceutical Sales Market Share in Value by Country (2024-2034)
Table 101. Middle East and Africa Specialty Pharmaceutical Sales by Country (2018-2024) & (MT)
Table 102. Middle East and Africa Specialty Pharmaceutical Sales Market Share in Volume by Country (2018-2024)
Table 103. Middle East and Africa Specialty Pharmaceutical Sales by Country (2018-2024) & (US$ Million)
Table 104. Middle East and Africa Specialty Pharmaceutical Sales Market Share in Value by Country (2018-2024)
Table 105. Middle East and Africa Specialty Pharmaceutical Sales by Country (2024-2034) & (MT)
Table 106. Middle East and Africa Specialty Pharmaceutical Sales Market Share in Volume by Country (2024-2034)
Table 107. Middle East and Africa Specialty Pharmaceutical Sales by Country (2024-2034) & (US$ Million)
Table 108. Middle East and Africa Specialty Pharmaceutical Sales Market Share in Value by Country (2024-2034)
Table 109. Pfizer Company Information
Table 110. Pfizer Introduction and Business Overview
Table 111. Pfizer Specialty Pharmaceutical Sales (MT), Revenue (Million USD), Price (USD/Kg) and Gross Margin (2018-2024)
Table 112. Pfizer Specialty Pharmaceutical Product
Table 113. Pfizer Recent Development
Table 114. Roche Company Information
Table 115. Roche Introduction and Business Overview
Table 116. Roche Specialty Pharmaceutical Sales (MT), Revenue (Million USD), Price (USD/Kg) and Gross Margin (2018-2024)
Table 117. Roche Specialty Pharmaceutical Product
Table 118. Roche Recent Development
Table 119. Amgen Company Information
Table 120. Amgen Introduction and Business Overview
Table 121. Amgen Specialty Pharmaceutical Sales (MT), Revenue (Million USD), Price (USD/Kg) and Gross Margin (2018-2024)
Table 122. Amgen Specialty Pharmaceutical Product
Table 123. Amgen Recent Development
Table 124. AbbVie Company Information
Table 125. AbbVie Introduction and Business Overview
Table 126. AbbVie Specialty Pharmaceutical Sales (MT), Revenue (Million USD), Price (USD/Kg) and Gross Margin (2018-2024)
Table 127. AbbVie Specialty Pharmaceutical Product
Table 128. AbbVie Recent Development
Table 129. Novo Nordisk Company Information
Table 130. Novo Nordisk Introduction and Business Overview
Table 131. Novo Nordisk Specialty Pharmaceutical Sales (MT), Revenue (Million USD), Price (USD/Kg) and Gross Margin (2018-2024)
Table 132. Novo Nordisk Specialty Pharmaceutical Product
Table 133. Novo Nordisk Recent Development
Table 134. Johnson & Johnson Company Information
Table 135. Johnson & Johnson Introduction and Business Overview
Table 136. Johnson & Johnson Specialty Pharmaceutical Sales (MT), Revenue (Million USD), Price (USD/Kg) and Gross Margin (2018-2024)
Table 137. Johnson & Johnson Specialty Pharmaceutical Product
Table 138. Johnson & Johnson Recent Development
Table 139. Sanofi-Aventis Company Information
Table 140. Sanofi-Aventis Introduction and Business Overview
Table 141. Sanofi-Aventis Specialty Pharmaceutical Sales (MT), Revenue (Million USD), Price (USD/Kg) and Gross Margin (2018-2024)
Table 142. Sanofi-Aventis Specialty Pharmaceutical Product
Table 143. Sanofi-Aventis Recent Development
Table 144. Merck Company Information
Table 145. Merck Introduction and Business Overview
Table 146. Merck Specialty Pharmaceutical Sales (MT), Revenue (Million USD), Price (USD/Kg) and Gross Margin (2018-2024)
Table 147. Merck Specialty Pharmaceutical Product
Table 148. Merck Recent Development
Table 149. Eli Lilly Company Information
Table 150. Eli Lilly Introduction and Business Overview
Table 151. Eli Lilly Specialty Pharmaceutical Sales (MT), Revenue (Million USD), Price (USD/Kg) and Gross Margin (2018-2024)
Table 152. Eli Lilly Specialty Pharmaceutical Product
Table 153. Eli Lilly Recent Development
Table 154. Novartis Company Information
Table 155. Novartis Introduction and Business Overview
Table 156. Novartis Specialty Pharmaceutical Sales (MT), Revenue (Million USD), Price (USD/Kg) and Gross Margin (2018-2024)
Table 157. Novartis Specialty Pharmaceutical Product
Table 158. Novartis Recent Development
Table 159. 3sbio Company Information
Table 160. 3sbio Introduction and Business Overview
Table 161. 3sbio Specialty Pharmaceutical Sales (MT), Revenue (Million USD), Price (USD/Kg) and Gross Margin (2018-2024)
Table 162. 3sbio Specialty Pharmaceutical Product
Table 163. 3sbio Recent Development
Table 164. Changchun High Tech Company Information
Table 165. Changchun High Tech Introduction and Business Overview
Table 166. Changchun High Tech Specialty Pharmaceutical Sales (MT), Revenue (Million USD), Price (USD/Kg) and Gross Margin (2018-2024)
Table 167. Changchun High Tech Specialty Pharmaceutical Product
Table 168. Changchun High Tech Recent Development
Table 169. CP Guojian Pharmacy Company Information
Table 170. CP Guojian Pharmacy Introduction and Business Overview
Table 171. CP Guojian Pharmacy Specialty Pharmaceutical Sales (MT), Revenue (Million USD), Price (USD/Kg) and Gross Margin (2018-2024)
Table 172. CP Guojian Pharmacy Specialty Pharmaceutical Product
Table 173. CP Guojian Pharmacy Recent Development
Table 174. Biotech Pharma Company Information
Table 175. Biotech Pharma Introduction and Business Overview
Table 176. Biotech Pharma Specialty Pharmaceutical Sales (MT), Revenue (Million USD), Price (USD/Kg) and Gross Margin (2018-2024)
Table 177. Biotech Pharma Specialty Pharmaceutical Product
Table 178. Biotech Pharma Recent Development
Table 179. Gelgen Biopharma Company Information
Table 180. Gelgen Biopharma Introduction and Business Overview
Table 181. Gelgen Biopharma Specialty Pharmaceutical Sales (MT), Revenue (Million USD), Price (USD/Kg) and Gross Margin (2018-2024)
Table 182. Gelgen Biopharma Specialty Pharmaceutical Product
Table 183. Gelgen Biopharma Recent Development
Table 184. Innovent Company Information
Table 185. Innovent Introduction and Business Overview
Table 186. Innovent Specialty Pharmaceutical Sales (MT), Revenue (Million USD), Price (USD/Kg) and Gross Margin (2018-2024)
Table 187. Innovent Specialty Pharmaceutical Product
Table 188. Innovent Recent Development
Table 189. Key Raw Materials Lists
Table 190. Raw Materials Key Suppliers Lists
Table 191. Specialty Pharmaceutical Market Trends
Table 192. Specialty Pharmaceutical Market Drivers
Table 193. Specialty Pharmaceutical Market Challenges
Table 194. Specialty Pharmaceutical Market Restraints
Table 195. Specialty Pharmaceutical Distributors List
Table 196. Specialty Pharmaceutical Downstream Customers
Table 197. Research Programs/Design for This Report
Table 198. Key Data Information from Secondary Sources
Table 199. Key Data Information from Primary Sources
List of Figures
Figure 1. Specialty Pharmaceutical Product Picture
Figure 2. Global Specialty Pharmaceutical Market Size, 2018 VS 2022 VS 2034 (US$ Million)
Figure 3. Global Specialty Pharmaceutical Market Size Status and Outlook (2018-2034) & (US$ Million)
Figure 4. Global Specialty Pharmaceutical Sales Status and Outlook (2018-2034) & (MT)
Figure 5. Product Picture of Antibody
Figure 6. Global Antibody Sales YoY Growth (2018-2034) & (MT)
Figure 7. Product Picture of Hormone
Figure 8. Global Hormone Sales YoY Growth (2018-2034) & (MT)
Figure 9. Product Picture of Growth Factors
Figure 10. Global Growth Factors Sales YoY Growth (2018-2034) & (MT)
Figure 11. Product Picture of Other
Figure 12. Global Other Sales YoY Growth (2018-2034) & (MT)
Figure 13. Global Specialty Pharmaceutical Sales by Type (2018-2034) & (US$ Million)
Figure 14. Global Specialty Pharmaceutical Sales Market Share by Type in 2022 & 2034
Figure 15. North America Specialty Pharmaceutical Sales Market Share in Volume by Type in 2022
Figure 16. North America Specialty Pharmaceutical Sales Market Share in Value by Type in 2022
Figure 17. Europe Specialty Pharmaceutical Sales Market Share in Volume by Type in 2022
Figure 18. Europe Specialty Pharmaceutical Sales Market Share in Value by Type in 2022
Figure 19. Asia-Pacific Specialty Pharmaceutical Sales Market Share in Volume by Type in 2022
Figure 20. Asia-Pacific Specialty Pharmaceutical Sales Market Share in Value by Type in 2022
Figure 21. Latin America Specialty Pharmaceutical Sales Market Share in Volume by Type in 2022
Figure 22. Latin America Specialty Pharmaceutical Sales Market Share in Value by Type in 2022
Figure 23. Middle East and Africa Specialty Pharmaceutical Sales Market Share in Volume by Type in 2022
Figure 24. Middle East and Africa Specialty Pharmaceutical Sales Market Share in Value by Type in 2022
Figure 25. The 5 and 10 Largest Manufacturers in the World: Market Share by Specialty Pharmaceutical Sales in 2022
Figure 26. The 5 and 10 Largest Manufacturers in the World: Market Share by Specialty Pharmaceutical Revenue in 2022
Figure 27. Specialty Pharmaceutical Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2018 VS 2022
Figure 28. Product Picture of Tumor
Figure 29. Global Tumor Sales YoY Growth (2018-2034) & (MT)
Figure 30. Product Picture of Diabetes
Figure 31. Global Diabetes Sales YoY Growth (2018-2034) & (MT)
Figure 32. Product Picture of Cardiovascular
Figure 33. Global Cardiovascular Sales YoY Growth (2018-2034) & (MT)
Figure 34. Product Picture of Hemophilia
Figure 35. Global Hemophilia Sales YoY Growth (2018-2034) & (MT)
Figure 36. Product Picture of Other
Figure 37. Global Other Sales YoY Growth (2018-2034) & (MT)
Figure 38. Global Specialty Pharmaceutical Sales by Application (2018-2034) & (US$ Million)
Figure 39. Global Specialty Pharmaceutical Sales Market Share by Application in 2022 & 2034
Figure 40. North America Specialty Pharmaceutical Sales Market Share in Volume by Application in 2022
Figure 41. North America Specialty Pharmaceutical Sales Market Share in Value by Application in 2022
Figure 42. Europe Specialty Pharmaceutical Sales Market Share in Volume by Application in 2022
Figure 43. Europe Specialty Pharmaceutical Sales Market Share in Value by Application in 2022
Figure 44. Asia-Pacific Specialty Pharmaceutical Sales Market Share in Volume by Application in 2022
Figure 45. Asia-Pacific Specialty Pharmaceutical Sales Market Share in Value by Application in 2022
Figure 46. Latin America Specialty Pharmaceutical Sales Market Share in Volume by Application in 2022
Figure 47. Latin America Specialty Pharmaceutical Sales Market Share in Value by Application in 2022
Figure 48. Middle East and Africa Specialty Pharmaceutical Sales Market Share in Value by Application in 2022
Figure 49. Key Raw Materials Price
Figure 50. Specialty Pharmaceutical Manufacturing Cost Structure
Figure 51. Specialty Pharmaceutical Industrial Chain Analysis
Figure 52. Channels of Distribution
Figure 53. Distributors Profiles
Figure 54. Bottom-up and Top-down Approaches for This Report
Figure 55. Data Triangulation
Figure 56. Key Executives Interviewed